March 25 (Reuters) - BioNTech said on Monday it has received a notice from the U.S. National Institutes of Health over default in payment of royalties and other amounts it allegedly owed the agency. (Reporting by Leroy Leo in Bengaluru; Editing by Shilpi Majumdar)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.13 USD | -0.83% | +0.20% | -14.60% |
05-08 | HC Wainwright Raises BioNTech SE Price Target to $113 From $107, Maintains Buy Rating | MT |
05-08 | BIONTECH : Deutsche Bank reaffirms its Neutral rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.60% | 21.72B | |
+2.93% | 108B | |
-2.62% | 23.46B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B | |
-24.02% | 8.32B |
- Stock Market
- Equities
- BNTX Stock
- News BioNTech SE
- BioNTech gets notice from NIH on default on royalties